239 related articles for article (PubMed ID: 8781331)
1. Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma.
Nakayama N; Kashiwazaki H; Kobayashi N; Hamada JI; Ogiso Y; Itakura Y; Matsumoto K; Nakamura T; Koike T; Kuzumaki N; Takeichi N
Hepatology; 1996 Sep; 24(3):596-602. PubMed ID: 8781331
[TBL] [Abstract][Full Text] [Related]
2. [Expression of hepatocyte growth factor (HGF) in LEC rats at various phases of hepatitis and hepatoma].
Nakayama N
Hokkaido Igaku Zasshi; 1995 Jul; 70(4):609-21. PubMed ID: 7590606
[TBL] [Abstract][Full Text] [Related]
3. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
5. Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does.
D'Errico A; Fiorentino M; Ponzetto A; Daikuhara Y; Tsubouchi H; Brechot C; Scoazec JY; Grigioni WF
Hepatology; 1996 Jul; 24(1):60-4. PubMed ID: 8707284
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
[TBL] [Abstract][Full Text] [Related]
8. The LEC rat: a model for human hepatitis, liver cancer, and much more.
Mori M; Hattori A; Sawaki M; Tsuzuki N; Sawada N; Oyamada M; Sugawara N; Enomoto K
Am J Pathol; 1994 Jan; 144(1):200-4. PubMed ID: 8291609
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats.
Shimamura M; Sato N; Sata M; Wakayama K; Ogihara T; Morishita R
Brain Res; 2007 Jun; 1151():188-94. PubMed ID: 17425951
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions.
Grigioni WF; Fiorentino M; D'Errico A; Ponzetto A; Crepaldi T; Prat M; Comoglio PM
Hepatology; 1995 Jun; 21(6):1543-6. PubMed ID: 7768498
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the hepatocyte growth factor receptor in regeneration and oncogenesis of hepatocytes].
Annen K
Hokkaido Igaku Zasshi; 1994 Mar; 69(2):301-11. PubMed ID: 8157255
[TBL] [Abstract][Full Text] [Related]
12. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
Nakamura T
Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
[TBL] [Abstract][Full Text] [Related]
15. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
[TBL] [Abstract][Full Text] [Related]
16. Expression of the c-met protooncogene in human hepatocellular carcinoma.
Suzuki K; Hayashi N; Yamada Y; Yoshihara H; Miyamoto Y; Ito Y; Ito T; Katayama K; Sasaki Y; Ito A
Hepatology; 1994 Nov; 20(5):1231-6. PubMed ID: 7927256
[TBL] [Abstract][Full Text] [Related]
17. Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats.
Kita Y; Masaki T; Funakoshi F; Yoshida S; Tanaka M; Kurokohchi K; Uchida N; Watanabe S; Matsumoto K; Kuriyama S
Int J Oncol; 2004 May; 24(5):1205-11. PubMed ID: 15067343
[TBL] [Abstract][Full Text] [Related]
18. Differing distribution of hepatocyte growth factor-positive cells in the liver of LEC rats with acute hepatitis, chronic hepatitis and hepatoma.
Nakayama N; Kashiwazaki H; Kobayashi N; Hamada J; Matsumoto K; Nakamura T; Takeichi N
Jpn J Cancer Res; 1995 Jan; 86(1):5-9. PubMed ID: 7737910
[TBL] [Abstract][Full Text] [Related]
19. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
[TBL] [Abstract][Full Text] [Related]
20. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
